In today's episode of Category Visionaries, we speak with Kourosh Davarpanah, Co-Founder and CEO of Inato, a global clinical trial platform that's raised over $35 Million in funding.
Topics Discussed:
Kourosh’s background coming from a family of doctors, fainting on the sight of blood, and being passionate about math and physics
Why Kourosh finds Airbnb inspiring
How less than 5% of the patient population have access to clinical trials, why this is a problem, and how Inato helps pharma companies coordinate wi...
In today's episode of Category Visionaries, we speak with Kourosh Davarpanah, Co-Founder and CEO of Inato, a global clinical trial platform that's raised over $35 Million in funding.
Topics Discussed:
- Kourosh’s background coming from a family of doctors, fainting on the sight of blood, and being passionate about math and physics
- Why Kourosh finds Airbnb inspiring
- How less than 5% of the patient population have access to clinical trials, why this is a problem, and how Inato helps pharma companies coordinate with hospitals to offer the right trials to their patients
- The chicken-and-egg problem of marketplace platforms, and how Kourosh dealt with it
- How to build credibility, and the danger of overfitting when working with only one client
Favorite book:
Complexity: The Emerging Science at the Edge of Order and Chaos
View more